SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-19-009666
Filing Date
2019-05-13
Accepted
2019-05-13 16:32:30
Documents
55
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q atos20190331_10q.htm 10-Q 519108
2 EXHIBIT 31.1 ex_141347.htm EX-31.1 11559
3 EXHIBIT 31.2 ex_141348.htm EX-31.2 11559
4 EXHIBIT 32.1 ex_141349.htm EX-32.1 6108
5 EXHIBIT 32.2 ex_141350.htm EX-32.2 6661
  Complete submission text file 0001437749-19-009666.txt   2934142

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT atos-20190331.xml EX-101.INS 480775
7 XBRL TAXONOMY EXTENSION SCHEMA atos-20190331.xsd EX-101.SCH 37604
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atos-20190331_cal.xml EX-101.CAL 29425
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atos-20190331_def.xml EX-101.DEF 247185
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE atos-20190331_lab.xml EX-101.LAB 218046
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atos-20190331_pre.xml EX-101.PRE 269270
Mailing Address 107 SPRING STREET SEATTLE WA 98104
Business Address 107 SPRING STREET SEATTLE WA 98104 206.588.0256
ATOSSA GENETICS INC (Filer) CIK: 0001488039 (see all company filings)

IRS No.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35610 | Film No.: 19818821
SIC: 2834 Pharmaceutical Preparations